Skip to main content
Nuwellis, Inc. (NUWE)
NASDAQ: NUWE · Real-Time Price · USD
1.300
-0.040 (-2.99%)
At close: Nov 20, 2024, 4:00 PM
1.280
-0.020 (-1.54%)
Pre-market: Nov 21, 2024, 5:38 AM EST

Nuwellis Revenue

Nuwellis had revenue of $2.37M in the quarter ending September 30, 2024, a decrease of -1.87%. This brings the company's revenue in the last twelve months to $8.97M, up 3.66% year-over-year. In the year 2023, Nuwellis had annual revenue of $8.86M with 3.76% growth.

Revenue (ttm)
$8.97M
Revenue Growth
+3.66%
P/S Ratio
0.07
Revenue / Employee
$152,017
Employees
59
Market Cap
2.43M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20238.86M321.00K3.76%
Dec 31, 20228.54M622.00K7.85%
Dec 31, 20217.92M480.00K6.45%
Dec 31, 20207.44M1.93M35.02%
Dec 31, 20195.51M513.00K10.26%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Molecular Templates 25.47M
ReShape Lifesciences 8.18M
Avinger 7.26M
Petros Pharmaceuticals 4.02M
NanoVibronix 3.29M
Sintx Technologies 3.25M
HeartSciences 18.60K
Revenue Rankings

NUWE News

More News